Samsung Biologics Completes Acquisition of GSK’s Manufacturing Facility In Rockville, Maryland

Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization (CDMO), today announced the completion of its acquisition of... Read More

The post Samsung Biologics Completes Acquisition of GSK’s Manufacturing Facility In Rockville, Maryland appeared first on citybiz.